survival outcomes

In-Hospital Cardiac Arrest in China: Incidence, Care Processes, and Survival Outcomes in a Multicenter Prospective Study

By MedXY 10/10/2026

This multicenter Chinese registry study reveals a high incidence of in-hospital cardiac arrest with low survival rates and highlights critical gaps in postresuscitation care and systemic factors limiting outcomes.

Hematology-Oncology news

Outcomes of Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Young Adults: Insights from the EBMT Chronic Malignancies Working Party

By MedXY 10/08/2026

This retrospective study evaluates survival outcomes and risk factors associated with allogeneic hematopoietic cell transplantation in young adults (18-40 years) with myelodysplastic syndrome, revealing encouraging survival rates and highlighting critical prognostic variables for personalized transplant strategies.

news OB/GYN & Women's Health Oncology

Ovarian-Sparing Surgery in Early-Stage Adult Granulosa Cell Tumors: Comparable Survival Outcomes to Bilateral Oophorectomy

By MedXY 10/06/2026

This study demonstrates that ovarian-sparing surgery in premenopausal patients with early-stage adult granulosa cell tumors offers survival outcomes similar to bilateral salpingo-oophorectomy, supporting fertility-preserving options in clinical practice.

Clinical Updates news Oncology

Contemporary Surgical Management of Vulvar Cancer: Balancing Improved Survival with Increased Reoperation Rates — Insights from a Finnish Nationwide Study

By MedXY 09/27/2026

This review synthesizes evidence that modern personalized surgical strategies for vulvar squamous cell carcinoma enhance survival outcomes despite higher reoperation rates, emphasizing evolving surgical techniques, sentinel lymph node biopsy, and reconstructive approaches.

Hematology-Oncology news

Global Real-World Evidence Shows Survival Benefit of Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple Myeloma

By MedXY 09/22/2026

Maintenance therapies—lenalidomide, thalidomide, and bortezomib—significantly improve survival after autologous stem cell transplant for multiple myeloma, regardless of initial response status, based on a large global registry analysis.

Diabetes & Endocrinology news Oncology

Evaluating First-Line Chemotherapy Strategies in Anaplastic Thyroid Cancer: Insights from a German Multicenter Registry

By MedXY 09/21/2026

A multicenter German registry study comparing carboplatin/paclitaxel to other chemotherapy regimens in anaplastic thyroid cancer found no survival advantage, highlighting the importance of molecular diagnostics and multimodal treatment approaches.

news Oncology Otorhinolaryngology

Immunotherapy in Head and Neck Squamous Cell Carcinoma with Low PD-L1 Expression: A Meta-Analytic Insight into Survival Outcomes

By MedXY 09/21/2026

A meta-analysis reveals immune checkpoint inhibitors may reduce survival in head and neck squamous cell carcinoma patients with PD-L1 combined positive scores less than 1, signaling caution in this subgroup's treatment.

Hematology-Oncology news

Contemporary Outcomes of Autologous Stem Cell Transplantation in AL Amyloidosis: Insights from a Decade-Long Multicenter Study

By MedXY 09/20/2026

A multicenter retrospective study of 1047 AL amyloidosis patients undergoing autologous stem cell transplantation (2010–2020) demonstrates improved safety, deep hematologic responses, and durable survival, affirming ASCT’s vital role in treatment paradigms.

Clinical Updates Hematology-Oncology news

Germline Lymphoma-Predisposing Variants: Influence on Age at Diagnosis and Survival Outcomes in Pediatric Patients

By MedXY 09/16/2026

This review synthesizes current evidence on germline lymphoma-predisposing variants, highlighting their impact on earlier cancer onset and variable survival rates in pediatric lymphoma patients, underscoring implications for genetic screening and personalized management.

Hematology-Oncology news Oncology

Comparing CHOP and CHOEP/EPOCH Regimens in Aggressive Adult T-Cell Leukemia/Lymphoma: Insights from an International Cohort Study

By MedXY 09/16/2026

This international cohort study evaluates the effectiveness of CHOEP/EPOCH versus CHOP chemotherapy in aggressive adult T-cell leukemia/lymphoma, revealing subtype-specific survival benefits in lymphomatous ATL but inconclusive results in acute ATL.

Diabetes & Endocrinology news Oncology

Impact of Hypercortisolism Severity on Outcomes in Adrenocortical Carcinoma with Cushing’s Syndrome

By MedXY 09/15/2026

This study reveals that the severity of hypercortisolism in adrenocortical carcinoma patients with Cushing’s syndrome correlates with higher metastatic risk and worse survival outcomes, highlighting its role as a marker of tumor aggressiveness.

Critical Care General Surgery news

Angioembolization vs. Surgery in Penetrating Hepatic Trauma: Balancing Survival and Hospital Stay

By MedXY 09/13/2026

In penetrating liver trauma, angioembolization offers survival outcomes comparable to surgery but is linked to longer hospital and ICU stays, highlighting the need for strategic patient selection and multidisciplinary care integration.

General Surgery news Oncology

Clinical Outcomes and Prognostic Factors in Lung Metastases Following Gastrectomy for Gastric Cancer

By MedXY 09/07/2026

This review summarizes the clinical characteristics, disease course, and survival outcomes of lung metastases after gastrectomy in gastric cancer patients, highlighting prognostic factors and the role of pulmonary metastasectomy.

news Oncology Otorhinolaryngology

Enhancing Care for Head and Neck Cancer Patients: Insights from a Novel Subspecialty Outpatient Palliative Medicine Clinic

By MedXY 09/03/2026

A surgeon-led outpatient palliative care clinic for head and neck cancer patients demonstrated significant symptom improvement, prolonged survival, and high rates of home or hospice deaths, underscoring its value in multidisciplinary cancer care.

General Surgery news Oncology

Neoadjuvant Chemotherapy with or without Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Impact on Outcomes

By MedXY 08/31/2026

A propensity-matched study shows adding radiotherapy to neoadjuvant chemotherapy improves pathologic response but does not enhance survival or reduce recurrence in resected pancreatic ductal adenocarcinoma.

General Surgery news Oncology

Adjuvant Chemotherapy in Distal Bile Duct Carcinoma: Insights from Real-World German Cancer Registry Data

By MedXY 08/28/2026

Adjuvant chemotherapy shows survival benefits in select subgroups of distal bile duct carcinoma patients post-surgery, emphasizing the need for tailored treatment strategies and further prospective research.

$Maximizing Outcomes in Locally Advanced Pancreatic Cancer with Hypofractionated Ablative Radiation Therapy$

General Surgery news Oncology

Maximizing Outcomes in Locally Advanced Pancreatic Cancer with Hypofractionated Ablative Radiation Therapy

By MedXY 08/02/2026

Hypofractionated ablative radiation therapy after induction chemotherapy shows promise in patients with locally advanced pancreatic cancer, improving resectability and 2-year survival while maintaining acceptable safety profiles.

news OB/GYN & Women’s Health Oncology

MLH1 Promoter Hypermethylation Does Not Impact Survival Outcomes in dMMR Endometrial Cancer Treated with Immune Checkpoint Inhibitors

By MedXY 08/01/2026

This study analyzes real-world data showing that MLH1 promoter hypermethylation and Lynch syndrome-associated genetic mutations confer similar response rates and survival outcomes in mismatch repair deficient endometrial cancer treated with immune checkpoint inhibitors.

Gastroenterology news Oncology

Comparing FLOT and CROSS Protocols: Survival and Recurrence in Esophageal Adenocarcinoma with Pathological Complete Response

By MedXY 07/24/2026

This cohort study compares long-term survival and recurrence in esophageal adenocarcinoma patients achieving pathological complete response (pCR) after neoadjuvant FLOT chemotherapy versus CROSS chemoradiotherapy, highlighting better outcomes with FLOT.

Dermatology news Oncology

Exploring Institutional and Insurance-Linked Disparities in Melanoma Outcomes: Insights from a VA and Tertiary Care Cohort Study

By MedXY 07/14/2026

This cohort study reveals differential melanoma survival outcomes linked to institutional settings and insurance types, highlighting the need for standardized care in advanced melanoma stages.